Table 2 Hospital AMS structures and activities, overall and by region
| Â | n (%) | n/n (%) | |||||
|---|---|---|---|---|---|---|---|
Africa (n = 38) | Asia (n = 91) | Europe (n = 61) | Latin America (n = 31) | Northern America (n = 24) | Total (n = 248) | Initiated as a result of PPS findings* | |
Local, evidence-based guidelines | 12 (31.6) | 69 (75.8) | 44 (72.1) | 24 (77.4) | 23 (95.8) | 175 (70.6) | 67/143 (46.9) |
Antimicrobial formulary | 9 (23.7) | 68 (74.7) | 41 (67.2) | 14 (45.2) | 21 (87.5) | 156 (62.9) | 42/126 (33.3) |
Education and communication | 15 (39.5) | 38 (41.8) | 40 (65.6) | 19 (61.3) | 16 (66.7) | 129 (52.0) | 50/98 (51.0) |
AMS committee** | 12 (31.6) | 46 (50.5) | 27 (44.3) | 16 (51.6) | 23 (95.8) | 127 (51.2) | 34/102 (33.3) |
AMS team†| 8 (21.1) | 42 (46.2) | 31( 50.8) | 16 (51.6) | 19 (79.2) | 119 (48.0) | 27/95 (28.4) |
Specific AMS interventions††| 7 (18.4) | 31 (34.1) | 24 (39.3) | 11 (35.5) | 23 (95.8) | 99 (39.9) | 32/81 (39.5) |
Information technology support | 1 (2.6) | 43 (47.3) | 14 (23.0) | 7 (22.6) | 9 (37.5) | 76 (30.6) | 25/62 (40.3) |
Other AMS activities | 1 (2.6) | 3 (3.3) | 2 (3.3) | 2 (6.5) | 2 (8.3) | 10 (4.0) | Â |
No AMS activities | 11 (28.9) | 6 (6.6) | 1 (1.6) | 2 (6.5) | 0 (0.0) | 20 (8.1) | Â |